Filter Results
:
(268)
Show Results For
-
All HBS Web
(1,742)
- Faculty Publications (268)
Show Results For
-
All HBS Web
(1,742)
- Faculty Publications (268)
- April 24, 2023
- Article
In the COVID Era, Why Corporate Benefits Demand CEO/CFO Leadership
The expectation that employers provide their employees’ health benefits has been around since World War II. Unfortunately, although today’s employees expect employers to treat them as individuals, ease their experiences, prioritize their wellbeing, and control cost,...
View Details
Keywords:
COVID;
COVID-19 Pandemic;
CEO;
Leadership;
Health Insurance;
Benefits;
CFO;
Compensation and Benefits
Herzlinger, Regina E. "In the COVID Era, Why Corporate Benefits Demand CEO/CFO Leadership." CMR Insights (April 24, 2023).
- March–April 2023
- Article
The New-Collar Workforce
By: Colleen Ammerman, Boris Groysberg and Ginni Rometty
Many workers today are stuck in low-paying jobs, unable to advance simply because they don’t have a bachelor’s degree. At the same time, many companies are desperate for workers and not meeting the diversity goals that could help them perform better while also reducing...
View Details
Ammerman, Colleen, Boris Groysberg, and Ginni Rometty. "The New-Collar Workforce." Harvard Business Review 101, no. 2 (March–April 2023): 96–103.
- March 2023
- Teaching Note
Hikma Pharmaceuticals Governance Journey
By: Suraj Srinivasan and Jonah Goldberg
Teaching Note for HBS Case No. 318108. The case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the multinational generics company, anticipating the company’s 2017 AGM and reflecting on changes made over the previous year to address concerns...
View Details
Keywords:
Jordan;
Emerging Market;
Private Sector;
For-profit Firms;
Boards Of Directors;
Pharmaceuticals;
Remuneration;
Shareholder Engagement;
Corporate Governance;
Governing and Advisory Boards;
Business and Shareholder Relations;
Executive Compensation;
Business Growth and Maturation;
Pharmaceutical Industry;
Jordan
- January 2023 (Revised August 2023)
- Case
Veeva Systems and the Transformation to a Public Benefit Corporation
By: Ranjay Gulati and Allison M. Ciechanover
Peter Gassner, the co-founder and CEO of Veeva Systems, steered the company through rapid scaling from its launch in 2007 to 2022. Year after year, the company had exceeded expectations, with its market capitalization reaching $50 billion at its peak. By 2022, the...
View Details
- January 2023
- Teaching Note
The Opioid Settlement and Executive Pay at AmerisourceBergen
By: Suraj Srinivasan and Li-Kuan Ni
Teaching Note for HBS Case No 122-014. In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged...
View Details
Keywords:
Opioids;
Shareholder Activism;
Investment Activism;
Corporate Accountability;
Corporate Governance;
Governance Compliance;
Governance Controls;
Executive Compensation;
Risk Management;
Corporate Social Responsibility and Impact;
Business and Shareholder Relations;
Business and Stakeholder Relations;
Distribution Industry;
Health Industry;
Pharmaceutical Industry;
United States;
West Virginia;
Tennessee;
Ohio;
Pennsylvania
- November 2022
- Case
Para: Pay Transparency and Gig Drivers' Rights
By: Christopher Stanton and George Gonzalez
The case presents the founding vision and early days of a young startup that seeks to empower delivery drivers with tools and transparency. The company's flagship mobile app has been taken up by tens of thousands of delivery drivers across major U.S. cities who use it...
View Details
- 2022
- Working Paper
How Do Investors Value ESG?
By: Malcolm Baker, Mark Egan and Suproteem K. Sarkar
Environmental, social, and governance (ESG) objectives have risen to near the top of the agenda for corporate executives and boards, driven in large part by their perceptions of shareholder interest. We quantify the value that shareholders place on ESG using a revealed...
View Details
Keywords:
Investment;
Investment Portfolio;
Corporate Social Responsibility and Impact;
Business and Shareholder Relations;
Environmental Sustainability;
Governance;
Financial Services Industry;
United States
Baker, Malcolm, Mark Egan, and Suproteem K. Sarkar. "How Do Investors Value ESG?" NBER Working Paper Series, No. 30708, December 2022. (Harvard Business School Working Paper, No. 23-028, November 2022.)
- 2022
- Article
The Effects of Public and Private Equity Markets on Firm Behavior
By: Shai Bernstein
In this article, I review the theoretical and empirical literature on the effects of public and private equity markets on firm behavior, emphasizing the consequences that emerge from disclosure requirements, ownership concentration, and degree of firm standardization....
View Details
Keywords:
Corporate Finance And Governance;
Financing Policy;
Commercialization;
Capital Markets;
Private Equity;
Public Equity;
Venture Capital;
Innovation and Invention;
Cost of Capital
Bernstein, Shai. "The Effects of Public and Private Equity Markets on Firm Behavior." Annual Review of Financial Economics 14 (2022): 295–318.
- October 2022 (Revised January 2024)
- Case
mPharma: Scaling Access to Affordable Primary Care in Africa
By: Regina E. Herzlinger and Ben Creo
mPharma hopes to scale up to create the largest pan-African healthcare company ever to provide much-needed primary care in retail pharmacies; a reliable, fairly priced supply of drugs; and micro-insurance for drugs. They must prioritize launching a telemedicine...
View Details
Keywords:
Africa;
Pharmaceutical Companies;
Pharmacy Benefit Manager;
Health Care;
Health Care And Treatment;
Health Care Costs;
Health Care Delivery;
Health Care Entrepreneurship;
Telehealth;
Health Equity;
Corporate Strategy;
Social Entrepreneurship;
Equity;
Growth and Development Strategy;
Expansion;
Product Launch;
Customer Value and Value Chain;
Social Enterprise;
Multinational Firms and Management;
Pharmaceutical Industry;
Health Industry;
Africa
Herzlinger, Regina E., and Ben Creo. "mPharma: Scaling Access to Affordable Primary Care in Africa." Harvard Business School Case 323-033, October 2022. (Revised January 2024.)
- 2022
- White Paper
The American Opportunity Index: A Corporate Scorecard of Worker Advancement
By: Matt Sigelman, Joseph Fuller, Nik Dawson and Gad Levanon
The American Opportunity Index: A Corporate Scorecard of Worker Advancement is a new effort to give companies and other stakeholders a set of robust tools that measure how well major employers are doing in fostering economic mobility for workers and how they could do...
View Details
Keywords:
Upward Mobility;
Career Advancement;
Personal Development and Career;
Compensation and Benefits;
Employees;
Wages;
Human Capital;
Recruitment
Sigelman, Matt, Joseph Fuller, Nik Dawson, and Gad Levanon. "The American Opportunity Index: A Corporate Scorecard of Worker Advancement." White Paper, Burning Glass Institute, October 2022 (A joint project with Harvard Business School Project on Managing the Future of Work and Schultz Family Foundation.)
- September 2022
- Article
Drivers of Philanthropic Foundations in Emerging Markets: Family, Values and Spirituality
By: Valeria Giacomin and Geoffrey Jones
This article discusses the ethics and drivers of philanthropic foundations in emerging markets. A foundation organizes assets to invest in philanthropic initiatives. Previous scholarship has largely focused on developed countries, especially the United States, and has...
View Details
Keywords:
Philanthropy;
Foundations;
Spirituality;
Philanthropy and Charitable Giving;
Social Enterprise;
Emerging Markets;
Values and Beliefs;
Africa;
Asia;
Latin America;
Middle East
Giacomin, Valeria, and Geoffrey Jones. "Drivers of Philanthropic Foundations in Emerging Markets: Family, Values and Spirituality." Journal of Business Ethics 180, no. 1 (September 2022): 263–282. (https://doi.org/10.1007/s10551-021-04875-4.)
- July 2022
- Case
David Crane’s Clean(er) Energy Strategy at NRG
By: George Serafeim, Michael W. Toffel and Tom Quinn
In 2015, David Crane was the CEO of NRG, the second-largest energy producer in the United States. NRG got most of its power from fossil fuels, but Crane – hired as CEO in 2003 as NRG emerged from bankruptcy – had invested heavily in alternative energy, loudly...
View Details
Keywords:
Energy;
Leadership;
Corporate Governance;
Transformation;
Alternative Energy;
Energy Generation;
Climate Change;
Corporate Accountability;
Renewable Energy;
Energy Industry;
United States
Serafeim, George, Michael W. Toffel, and Tom Quinn. "David Crane’s Clean(er) Energy Strategy at NRG." Harvard Business School Case 623-005, July 2022.
- 2022
- Working Paper
A Conceptualization of Sub-Living Wages: Liabilities, Leverage, and Risk
By: Drew Keller, Katie Panella and George Serafeim
Currently the accounting system records employee wages as an expense in the income statement. However, paying below living wages can expose an organization to reputational and operational risks. In this paper, we offer an alternative conceptualization of the issue of...
View Details
Keywords:
Accounting;
Impact Accounting;
Leverage;
Wages;
Compensation and Benefits;
Business and Stakeholder Relations;
Business and Government Relations;
Social Issues;
Human Capital
Keller, Drew, Katie Panella, and George Serafeim. "A Conceptualization of Sub-Living Wages: Liabilities, Leverage, and Risk." Harvard Business School Working Paper, No. 22-076, June 2022.
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a...
View Details
Keywords:
Health;
COVID-19 Pandemic;
Primary Care;
Leadership;
Change Management;
Women Executives;
Retail;
Pharmacy;
Pharmacy Benefit Manager;
Clinical Trials;
Vaccination;
Acquisition;
Innovation and Invention;
Transformation;
Retail Industry;
Pharmaceutical Industry;
Health Industry;
United States
- March 2022 (Revised January 2023)
- Case
Clara Wu Tsai and Brooklyn Loan Innovation
Philanthropist Clara Wu Tsai is committed to racial equity and investing in Brooklyn-based minority business owners. In the wake of the George Floyd murder, she decides to create a new initiative called the Social Justice Fund and commit an initial $50 million over 10...
View Details
- March 2022 (Revised October 2022)
- Case
Transforming Kimball International, Inc. (A)
By: Lynn S. Paine and Will Hurwitz
Kimball International, Inc. (KII), led by CEO Kristie Juster, and its board of directors, chaired by Kim Ryan, faced critical questions about KII’s future in the spring of 2021. Two years earlier, the board had appointed Juster as the new CEO of KII, a publicly traded,...
View Details
Keywords:
Board Of Directors;
Board Committees;
Board Decisions;
Board Dynamics;
CEO Compensation;
CEO Succession;
Compensation Committee;
Compensation Consultants;
Compensation Design;
Compensation Mix;
Corporate Purpose;
COVID-19;
ESG;
Furniture;
Furniture Industry;
Manufacturing;
Midwest;
Pandemic;
Purpose;
Spin Off;
Strategic Change;
Strategic Decisions;
Strategic Evolution;
Target-setting;
Executive Compensation;
Family Ownership;
Governance;
Restructuring;
Strategy;
Transformation;
Manufacturing Industry;
United States
Paine, Lynn S., and Will Hurwitz. "Transforming Kimball International, Inc. (A)." Harvard Business School Case 322-083, March 2022. (Revised October 2022.)
- March 2022
- Supplement
Transforming Kimball International, Inc. (B)
By: Lynn S. Paine and Will Hurwitz
Supplements the (A) case.
View Details
Keywords:
Board Of Directors;
Board Committees;
Board Decisions;
Board Dynamics;
CEO Compensation;
CEO Succession;
Compensation Committee;
Compensation Consultants;
Compensation Design;
Compensation Mix;
Corporate Purpose;
COVID-19;
ESG;
Furniture;
Furniture Industry;
Manufacturing;
Midwest;
Pandemic;
Purpose;
Spin-off;
Strategic Change;
Strategic Decisions;
Strategic Evolution;
Target-setting;
Executive Compensation;
Family Ownership;
Governance;
Restructuring;
Strategy;
Transformation;
Manufacturing Industry;
United States
Paine, Lynn S., and Will Hurwitz. "Transforming Kimball International, Inc. (B)." Harvard Business School Supplement 322-084, March 2022.
- March 2022 (Revised April 2022)
- Teaching Note
France Télécom (A), (B), and (C)
By: Ashley Whillans
This case series discusses the evolution of France Télécom (now Orange) from a national telephone monopoly to a private company. During this process, the company faced numerous challenges including the entry of new competition from other countries and a workforce that...
View Details
- February 2022 (Revised April 2022)
- Case
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Tuna Cem Hayirli
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant. The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a...
View Details
Keywords:
COVID;
Caregiving;
Healthcare;
Access;
Change;
Retail;
Health;
Health Care and Treatment;
Organizational Change and Adaptation;
Transformation;
Health Industry;
Retail Industry
Kanter, Rosabeth Moss, and Tuna Cem Hayirli. "CVS Health: Prescription for Transformation." Harvard Business School Case 322-091, February 2022. (Revised April 2022.)
- February 2022
- Case
Agora (A)
By: Lindsay N. Hyde, Thomas R. Eisenmann and Tom Quinn
Agora was a civic technology (civic tech) startup founded by Elsa Sze, who wanted to enhance the connection between political officials and their constituents by facilitating virtual “town halls,” making underrepresented voices heard and benefiting elected and...
View Details
Keywords:
Civic Technology;
Government Administration;
Conferences;
Business Startups;
Business Strategy
Hyde, Lindsay N., Thomas R. Eisenmann, and Tom Quinn. "Agora (A)." Harvard Business School Case 822-022, February 2022.